Revolučná génová terapia na zníženie cholesterolu

VERVE-102 jednorazovo vypína gén PCSK9 a znižuje LDL cholesterol až o 69%. V štúdii neboli hlásené vážne vedľajšie účinky. Môže nahradiť celoživotné užívanie statínov.

https://www.sciencefocus.com/news/new-cholesterol-treatment-could-be-revolutionary-verve

‘This is revolutionary!’: Breakthrough cholesterol treatment can cut levels by 69% after one dose | BBC Science Focus Magazine

www.sciencefocus.com

‘This is revolutionary!’: Breakthrough cholesterol treatment can cut levels by 69% after one dose | BBC Science Focus Magazine

The future of heart attack prevention could be as easy as a single injection